AxoGen, Inc.
AXGN
$14.83
-$1.43-8.80%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 16.68% | -1.71% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 16.68% | -1.71% | |||
| Cost of Revenue | 7.46% | 15.19% | |||
| Gross Profit | 20.28% | -7.03% | |||
| SG&A Expenses | 9.80% | 5.71% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.50% | 5.98% | |||
| Operating Income | 200.66% | -182.35% | |||
| Income Before Tax | 115.10% | -952.00% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 115.10% | -952.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 115.10% | -952.00% | |||
| EBIT | 200.66% | -182.35% | |||
| EBITDA | 2,433.58% | -96.40% | |||
| EPS Basic | 114.86% | -948.00% | |||
| Normalized Basic EPS | 114.91% | -941.27% | |||
| EPS Diluted | 111.79% | -948.00% | |||
| Normalized Diluted EPS | 114.15% | -998.31% | |||
| Average Basic Shares Outstanding | 1.90% | 0.73% | |||
| Average Diluted Shares Outstanding | 6.14% | -5.95% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||